Skip to main content
Clinical Journal of the American Society of Nephrology : CJASN logoLink to Clinical Journal of the American Society of Nephrology : CJASN
editorial
. 2020 Oct 22;15(11):1539–1540. doi: 10.2215/CJN.14870920

Fatigue While Undergoing Long-Term Hemodialysis

Henning Sondergaard 1,
PMCID: PMC7646235  PMID: 33170137

Fatigue is a common symptom for people living with late-stage CKD, with a diminishing effect on quality of life for many patients (1). Unfortunately, hemodialysis (HD) initiation does not assuage fatigue for most patients on this treatment type (2).

Being both a patient and a health psychologist, I took an interest in fatigue and other cognitive effects of late-stage CKD almost 2 decades ago. Once I began experiencing changes in my ability to think straight while I was still at stage 4, I started wondering about the reason for this deficit. My nephrologist and others on my treatment team were not able to offer any insights beyond the fact that fatigue is “normal” in advanced CKD.

When I started doing my own research, one of the first things I noticed was the paucity of studies on fatigue and other cognitive changes. I observed that most of the literature in that domain concentrated on depression and anxiety, but fatigue and other cognitive deficits, such as memory loss, lack of concentration, and other executive functions, were poorly researched—and that holds true to this day.

In the past decade, the focus on patient-reported outcomes and its measures has increased. I hope we will start to see more studies about fatigue and other cognitive deficits caused by ESKD once reports from patients are acknowledged as a serious metric by clinicians and researchers.

Despite being one of the most typical complaints among people on dialysis (3), there has been no patient-reported outcome measure for fatigue in HD until the “Standard Outcomes in Nephrology-Hemodialysis Fatigue” measure (4) described in a study by Ju et al. and published in this issue of CJASN. Up until now, we have had to rely on instruments developed for nondialysis-specific purposes.

The Standard Outcomes in Nephrology-Hemodialysis Fatigue measure is easy to use and measures a global fatigue score over the past week, which is great for many practical purposes. It captures the most important fatigue domains for people on HD: tiredness, lack of energy, and inability to participate in social situations.

Sadly, it does not capture an important dimension of fatigue for people doing dialysis: the difference between postdialysis fatigue (PDF) and interdialytic fatigue (IDF). Postdialysis fatigue may last from a few minutes to more than 12 hours (5). For many patients, this is the most debilitating part of their treatment. There is most likely some causation between the treatment itself and PDF, whereas IDF is reminiscent of the type of fatigue experienced before dialysis initiation. There is much speculation about the cause(s) of dialysis-related fatigue, but sociodemographic, biologic, and psychologic factors all seem to be associated with both types of fatigue (6).

One of the things that may diminish both PDF and IDF is a longer and more frequent treatment regime (7). People doing more frequent dialysis regularly report that the trade-off between the time in treatment and time off the machine is well worth it. The extra time they spent in treatment is returned to them by having more energy and increased quality of life when not in treatment. In fact, the vast majority of people I have talked to as a psychologist who do either nocturnal or frequent dialysis (>20 h/wk) experience no PDF and very little, if any, IDF.

So, perhaps the problem with fatigue in hemodialysis is amplified by the way in which HD is currently administered. From a patient standpoint, it would be interesting to see further studies examining the connection between fatigue and more frequent treatment regimes—especially when keeping in mind that more frequent dialysis regimes also improve quality of life and longevity (8) in dialysis patients.

Disclosures

The author has nothing to disclose.

Funding

None.

Acknowledgments

The content of this article reflects the personal experience and views of the author(s) and should not be considered medical advice or recommendation. The content does not reflect the views or opinions of the American Society of Nephrology (ASN) or CJASN. Responsibility for the information and views expressed herein lies entirely with the author(s).

Footnotes

Published online ahead of print. Publication date available at www.cjasn.org.

See related editorial, “Moving the Science of Patient-Reported Outcome Measures Forward: Measuring Fatigue in Hemodialysis Patients,” and article, “Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis: The SONG-HD Fatigue Instrument,” on pages 1546–1548 and 1614–1621, respectively.

References

  • 1.Davey CH, Webel AR, Sehgal AR, Voss JG, Huml A: Fatigue in individuals with end stage renal disease. Nephrol Nurs J 46: 497–508, 2019. [PMC free article] [PubMed] [Google Scholar]
  • 2.Jhamb M, Weisbord SD, Steel JL, Unruh M: Fatigue in patients receiving maintenance dialysis: A review of definitions, measures, and contributing factors. Am J Kidney Dis 52: 353–365, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Sautenet B, O’Donoghue D, Tam-Tham H, Youssouf S, Mandayam S, Ju A, Hawley C, Pollock C, Harris DC, Johnson DW, Rifkin DE, Tentori F, Agar J, Polkinghorne KR, Gallagher M, Kerr PG, McDonald SP, Howard K, Howell M, Craig JC; Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Initiative : Developing a set of core outcomes for trials in hemodialysis: An international Delphi survey. Am J Kidney Dis 70: 464–475, 2017. [DOI] [PubMed] [Google Scholar]
  • 4.Ju A, Teixeira-Pinto A, Tong A, Smith AC, Unruh M, Davison SN, Dapueto J, Dew MA, Fluck R, Germain MJ, Jassal SV, Obrador GT, O’Donoghue D, Viecelli AK, Strippoli G, Ruospo M, Timofte D, Sharma A, Au E, Howell M, Costa DSJ, Anumudu S, Craig JC, Rutherford C: Validation of a core patient-reported outcome measure for fatigue in patients receiving hemodialysis: The SONG-HD Fatigue instrument. Clin J Am Soc Nephrol 15: 1614–1621, 2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM: Recovery time, quality of life, and mortality in hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 64: 86–94, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Artom M, Moss-Morris R, Caskey F, Chilcot J: Fatigue in advanced kidney disease. Kidney Int 86: 497–505, 2014. [DOI] [PubMed] [Google Scholar]
  • 7.Van Eps CL, Jeffries JK, Johnson DW, Campbell SB, Isbel NM, Mudge DW, Hawley CM: Quality of life and alternate nightly nocturnal home hemodialysis. Hemodial Int 14: 29–38, 2010. [DOI] [PubMed] [Google Scholar]
  • 8.Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM; Frequent Hemodialysis Network Trial Group : Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol 7: 782–794, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Journal of the American Society of Nephrology : CJASN are provided here courtesy of American Society of Nephrology

RESOURCES